124 related articles for article (PubMed ID: 28960148)
1. Perinatal lethality of Par4
French SL; Hamilton JR
Platelets; 2018 Mar; 29(2):196-198. PubMed ID: 28960148
[TBL] [Abstract][Full Text] [Related]
2. Redundancy and interaction of thrombin- and collagen-mediated platelet activation in tail bleeding and carotid thrombosis in mice.
Bynagari-Settipalli YS; Cornelissen I; Palmer D; Duong D; Concengco C; Ware J; Coughlin SR
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2563-9. PubMed ID: 25278288
[TBL] [Abstract][Full Text] [Related]
3. Impaired hemostasis and protection against thrombosis in protease-activated receptor 4-deficient mice is due to lack of thrombin signaling in platelets.
Hamilton JR; Cornelissen I; Coughlin SR
J Thromb Haemost; 2004 Aug; 2(8):1429-35. PubMed ID: 15304051
[TBL] [Abstract][Full Text] [Related]
4. Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability.
Lee RH; Kawano T; Grover SP; Bharathi V; Martinez D; Cowley DO; Mackman N; Bergmeier W; Antoniak S
J Thromb Haemost; 2022 Feb; 20(2):422-433. PubMed ID: 34689407
[TBL] [Abstract][Full Text] [Related]
5. Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis.
Van Doren L; Nguyen N; Garzia C; Fletcher EK; Stevenson R; Jaramillo D; Kuliopulos A; Covic L
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e33-e45. PubMed ID: 33267659
[TBL] [Abstract][Full Text] [Related]
6. A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity.
Han X; Knauss EA; Fuente M; Li W; Conlon RA; LePage DF; Jiang W; Renna SA; McKenzie SE; Nieman MT
J Thromb Haemost; 2024 Jun; 22(6):1715-1726. PubMed ID: 38508397
[TBL] [Abstract][Full Text] [Related]
7. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.
Vandendries ER; Hamilton JR; Coughlin SR; Furie B; Furie BC
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):288-92. PubMed ID: 17190826
[TBL] [Abstract][Full Text] [Related]
8. Combined deficiency of protease-activated receptor-4 and fibrinogen recapitulates the hemostatic defect but not the embryonic lethality of prothrombin deficiency.
Camerer E; Duong DN; Hamilton JR; Coughlin SR
Blood; 2004 Jan; 103(1):152-4. PubMed ID: 14504091
[TBL] [Abstract][Full Text] [Related]
9. Human and mouse PAR4 are functionally distinct receptors: Studies in novel humanized mice.
Renna SA; Michael JV; Kong X; Ma L; Ma P; Nieman MT; Edelstein LC; McKenzie SE
J Thromb Haemost; 2022 May; 20(5):1236-1247. PubMed ID: 35152546
[TBL] [Abstract][Full Text] [Related]
10. Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis.
Cornelissen I; Palmer D; David T; Wilsbacher L; Concengco C; Conley P; Pandey A; Coughlin SR
Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18605-10. PubMed ID: 20930120
[TBL] [Abstract][Full Text] [Related]
11. Systems biology insights into the meaning of the platelet's dual-receptor thrombin signaling.
Sveshnikova AN; Balatskiy AV; Demianova AS; Shepelyuk TO; Shakhidzhanov SS; Balatskaya MN; Pichugin AV; Ataullakhanov FI; Panteleev MA
J Thromb Haemost; 2016 Oct; 14(10):2045-2057. PubMed ID: 27513817
[TBL] [Abstract][Full Text] [Related]
12. Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding.
Wong PC; Seiffert D; Bird JE; Watson CA; Bostwick JS; Giancarli M; Allegretto N; Hua J; Harden D; Guay J; Callejo M; Miller MM; Lawrence RM; Banville J; Guy J; Maxwell BD; Priestley ES; Marinier A; Wexler RR; Bouvier M; Gordon DA; Schumacher WA; Yang J
Sci Transl Med; 2017 Jan; 9(371):. PubMed ID: 28053157
[TBL] [Abstract][Full Text] [Related]
13. Role of thrombin signalling in platelets in haemostasis and thrombosis.
Sambrano GR; Weiss EJ; Zheng YW; Huang W; Coughlin SR
Nature; 2001 Sep; 413(6851):74-8. PubMed ID: 11544528
[TBL] [Abstract][Full Text] [Related]
14. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.
Leger AJ; Jacques SL; Badar J; Kaneider NC; Derian CK; Andrade-Gordon P; Covic L; Kuliopulos A
Circulation; 2006 Mar; 113(9):1244-54. PubMed ID: 16505172
[TBL] [Abstract][Full Text] [Related]
15. Atherosclerosis proceeds independently of thrombin-induced platelet activation in ApoE-/- mice.
Hamilton JR; Cornelissen I; Mountford JK; Coughlin SR
Atherosclerosis; 2009 Aug; 205(2):427-32. PubMed ID: 19217621
[TBL] [Abstract][Full Text] [Related]
16. A dual thrombin receptor system for platelet activation.
Kahn ML; Zheng YW; Huang W; Bigornia V; Zeng D; Moff S; Farese RV; Tam C; Coughlin SR
Nature; 1998 Aug; 394(6694):690-4. PubMed ID: 9716134
[TBL] [Abstract][Full Text] [Related]
17. The C-Type Lectin Receptor CD93 Regulates Platelet Activation and Surface Expression of the Protease Activated Receptor 4.
Trivigno SMG; Vismara M; Canobbio I; Rustichelli S; Galvagni F; Orlandini M; Torti M; Guidetti GF
Thromb Haemost; 2024 Feb; 124(2):122-134. PubMed ID: 37669782
[TBL] [Abstract][Full Text] [Related]
18. Determination of PAR4 numbers on the surface of human platelets: no effect of the single nucleotide polymorphism rs773902.
Li S; Tarlac V; Christanto RBI; French SL; Hamilton JR
Platelets; 2021 Oct; 32(7):988-991. PubMed ID: 32819173
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of monoclonal antibodies against Protease Activated Receptor 4 (PAR4).
Mumaw MM; de la Fuente M; Arachiche A; Wahl JK; Nieman MT
Thromb Res; 2015 Jun; 135(6):1165-71. PubMed ID: 25890453
[TBL] [Abstract][Full Text] [Related]
20. Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions.
Rigg RA; Healy LD; Chu TT; Ngo ATP; Mitrugno A; Zilberman-Rudenko J; Aslan JE; Hinds MT; Vecchiarelli LD; Morgan TK; Gruber A; Temple KJ; Lindsley CW; Duvernay MT; Hamm HE; McCarty OJT
Platelets; 2019; 30(1):126-135. PubMed ID: 30560697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
